Melioidosis and Pandemic Influenza
Article Sidebar
Main Article Content
Abstract
Secondary bacterial pneumonia complication after influenza viral infection is the major caused of death in pandemic influenza of an out break in 1918 and multiple subsequent epidemic and inter-epidemic periods.1
The bacteria commonly reported complication after influenza are Streptococcus pneumonia, Staphylococcus aureus and Haemophilus influenzae.2,3 Occasionally other bacterials reports varied to the endemic pathogens. The report 2 cases of probable melioidosis complicated after influenza viral pandemic 2009 are presented.
Article Details
This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
2. Rothber MB, Haessler SD, Brown RB. Complication of Viral Influenza. J Am J Med 2008;121:258-264
3. Hageman JC, Uyeki TM, Francis JS, et al. Severe Community acquired Pneumonia Due to Staphylococcus aureus, 2003-04 Influenza Season. Emerg Infect Dis 2006;12(6):894-899
4. Cheng AC, Lurrie BJ. Melioidosis: Epidemilogy, pathophysiology and Management. Clin Microbial Rev 2005;18(2):383-416
5. Currie BJ. Melioidosis: an important cause of pneumonia in residents of and travelers retuned from endemic regions. Eur Respir J 2003;22:542-550
6. Leelarasamee A. Melioidosis in Southeast Asia. Am J Trop Med Hyg 1999;60:458-461
7. Punyagupta S. Melioidosis. Review of 686 cases and presentation of a new clinical classification. In Punyagupta S, Sirisonthana T, Stapatayavong B, eds. Melioidosis. Bangkok. Bangkok Medical Publisher 1989;217-229
8. Mackowick PA, Smith JW. Septicemic melioidosis. Occurrence following acute influenza six years after exposure in Vietnam. JAMA 1978;240:704-766
9. Currie B, Smith VH, Golledge C, et al. Pseudomonas pseudomellis isolates collected over at years from a non-tropical endemic focus show clonality on the basic of ribotyping. Epidemiology Infect 1994;113:307-312
10 Shah PB, Giudice JC, Griesback R, et al. The Newer Guidelines for the Management of Community- Acquired Pneumonia. JAOA 2004;104(12):521-526
11. Sookpranee, M, Boonma P, Susaengrat W, et al. Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe aelioidosis. Antimicrob. Agents Chemother 1992;36:158-162
12. Thamprajamchit S, Chetchotisakd P, Thinkhamrop B. Cefoperazone/ sulbactam + co- trimoxazole vs. ceftrazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study. J. Med. Assoc Thai 1998;81:265-271
13. Boonma P, Boonsavat W, Patjanasoontron B, et al. The Efficacy of Imipenem/Cllastatin in teh Treatment of Melioidosis : P Preliminary Report from Srinagarind Hospital. J Infect Dis Antimicrob Agents 1990;7:65-69
14. Simpson A, Suputtamongkol Y. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 1999;19(2):381-387